发明名称 |
PACLITAXEL ENHANCER COMPOUNDS |
摘要 |
Disclosed is a compound represented by the Structural Formula (I):;;Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C═Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(R7R8)—.;R1 and R2 are independently an aryl group or a substituted aryl group, R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.;R5-R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.;R7 and R8 are each independently —H, an aliphatic or substituted aliphatic group, or R7 is —H and R8 is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2-C6 substituted or unsubstituted alkylene group.;Z is ═O or ═S.;Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent.;Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with Paclitaxel or an analog of Paclitaxel. |
申请公布号 |
US2015344420(A1) |
申请公布日期 |
2015.12.03 |
申请号 |
US201514826889 |
申请日期 |
2015.08.14 |
申请人 |
Synta Pharmaceuticals Corp. |
发明人 |
Koya Keizo;Sun Lijun;Chen Shoujun;Tatsuta Noriaki;Wu Yaming;Ono Mitsumori |
分类号 |
C07C327/56 |
主分类号 |
C07C327/56 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound represented by the following structural formula:or a pharmaceutically acceptable salt thereof, wherein:
Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group, or, Y, taken together with both >C═Z groups to which it is bonded, is a substituted or unsubstituted aromatic group; R1 and R2 are independently an aryl group or a substituted aryl group; R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group; R5-R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group; and Z is ═O or ═S; provided that when Y is —CH2—, R3 and R4 are both phenyl and R5-R6 are all —H, then R1 and R2 are not both phenyl. |
地址 |
Lexington MA US |